- This card faded exactly like a hyped rookie card is supposed to — a hot debut, then a long, steady decline through most of its first year and a half.
- A real health scare — not market sentiment — pushed it to its quietest point yet, right as the player was a Defensive Player of the Year frontrunner.
- A historic comeback season reignited it entirely, and the rebound has gone well past the original hype peak — in both price and how often it's trading.
- Compare that to a genuine faded-rookie case in the same set: Anthony Edwards' card spiked the same way, crashed the same way, and has simply stayed flat for three years — no second act, because the résumé never arrived.
Most rookie-card runs follow a predictable arc: a hot debut, a flood of speculative buying, and then a slow fade as attention moves to whoever's playing tonight. Victor Wembanyama's card followed that exact script — for about a year and a half. What happened after is the more interesting part.
We pulled the weekly trading data for this card — price, how often it sold, how much money changed hands — going back to its very first sale in May 2024, and lined it up against what was actually happening in his career, month by month. We did the same for a comparable rookie debut in our set, to see whether this one was actually behaving differently or just felt that way. Here's what the data shows.
The fade, right on schedule
When his card debuted in May 2024, the weekly numbers show exactly what every hyped rookie card does: a sharp initial spike in both price and how often it was trading, immediately after he was named Rookie of the Year. From there, the trend lines do the other thing hyped rookie cards do — they fade, steadily, week over week, for well over a year. By the back half of 2025, both the price and the pace of trading had fallen a long way from that debut spike, and the decline shows up cleanly in the data with no real bounce along the way. If the story stopped there, this would be an unremarkable card: a hot debut that cooled off, like dozens of others.
Then it got worse, for a real reason
In late February 2025, Wembanyama was diagnosed with a blood clot — deep vein thrombosis — in his shoulder and shut down for the rest of the season. At the time, he was putting up numbers only a handful of players in NBA history have ever matched over a full season, and he was the frontrunner for Defensive Player of the Year. None of that mattered to his card in the moment: when we mapped his health timeline against the weekly trading data, the quietest stretch in this card's entire history lines up almost exactly with the months he was sidelined and his basketball future was genuinely uncertain.
The card's quietest stretch wasn't about fading hype. It was about a health scare nobody could price in.
Then everything changed
Cleared to return for the 2025-26 season, Wembanyama didn't just come back — he had one of the most dominant seasons a young player has had in years: Defensive Player of the Year, a top-three finish in MVP voting, and the Spurs' first playoff appearance since before he joined the league. In the Western Conference Finals, he put up a 41-point, 24-rebound game against the defending champions. Tracking the weekly data through that stretch, the card's reignition lines up almost exactly with that run — both the price and the pace of trading climbed together, week after week, and by the time this piece is being written, both have gone well past where they were at the original rookie-year peak.
That's the detail that matters most: this isn't the same kind of move as the original debut spike. A debut spike is a bet on potential. This one is a market catching up to a guy who just had a Defensive Player of the Year season and a deep playoff run — production that didn't exist at any point during the original hype.
What a faded rookie card actually looks like
It's worth seeing the alternative, because it's sitting right next to this one in the same set. We ran the same weekly analysis on Anthony Edwards' card, and the early shape is almost identical: a hyped #1-pick debut, a sharp run-up, a hard crash. The difference shows up in what the data does after that: essentially nothing. For three years now, the weekly numbers have stayed in roughly the same depressed range, with no second wave to speak of. He's a good, productive player — but the All-NBA-level résumé that would justify a comeback like Wembanyama's hasn't arrived yet, and the trading data reflects exactly that. Same shape on the way down. Completely different story on the way back up, because one player's on-court story kept going and the other's is still waiting for its next chapter.
That's really the question we keep coming back to with cards like this, and the one worth asking about the market more broadly: when a price moves, is it because something actually changed, or because attention briefly pointed somewhere? For Wembanyama's card, the answer is about as clear as this market gets. For Edwards' — at least so far — it isn't there yet.